August 4, 2021 Comments Off on New patent expiration for Boehringer Ingelheim drug STRIVERDI RESPIMAT Posted in: Uncategorized
Annual Drug Patent Expirations for STRIVERDI+RESPIMAT Striverdi Respimat is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are fourteen…
The post New patent expiration for Boehringer Ingelhe…
August 4, 2021 Comments Off on New patent expiration for Boehringer Ingelheim drug COMBIVENT RESPIMAT Posted in: Uncategorized
Annual Drug Patent Expirations for COMBIVENT+RESPIMAT Combivent Respimat is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are seven…
The post New patent expiration for Boehringer Ingelheim …
